News

IREMEDY PROCURES SUPPLY OF 500 MILLION MORE LOW-DEAD SPACE SYRINGES AND NEEDLES IN SUPPORT OF PROJECT VACCINATE

Project Restart
STUART, FL – (GLOBE NEWSWIRE) – February 17, 2021 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that the Company has arranged for the procurement of an additional 500 million low-dead space syringes and needles in association with iRemedy’s “Project Vaccinate” initiative, created to support global demand for FDA-approved injection devices required for administration of COVID-19 vaccinations.
5 months ago

iRemedy’s “Project Vaccinate” Program is Gaining Traction in 2021 with Over 130 Million Needles and Syringes Delivered

Project Restart
STUART, FL – (GLOBE NEWSWIRE) – February 17, 2021 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in association with the Company’s effort to procure and deliver one billion FDA-approved hypodermic needles and syringes in support of COVID-19 vaccination programs worldwide, over 130 million units have been delivered to customers since announcing its program in November 2020.
6 months ago

iRemedy Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations

STUART, FL – November 18, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.
9 months ago

iRemedy’s Project Restart Has Shipped 50 Care Boxes To In-Need Community Medical Centers Since Launching In Early August

Project Restart
STUART, FL – September 21, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced that a total of 50 care box donations have now been shipped to underserved, underfunded community medical centers and clinics in association with iRemedy’s Project Restart program launched in early August 2020.
11 months ago

iRemedy’s Project Restart Continues to Gain Momentum, Shipping Donated Medical Supplies to 15 More In-Need Clinics

Project Restart
STUART, FL – August 24, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced that over the past week, the Company has shipped Project Restart ‘care boxes’ to 15 more community care organizations providing care to patients in underserved, underprivileged communities and neighborhoods in the U.S.; bringing the total to over 21 shipments since the program’s launch on August 5, 2020.
1 year ago

iRemedy’s Project Restart Having Immediate Impact on Underserved, Underfunded Community Care Providers

Project Restart
STUART, FL – August 13, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, announced that the launch of Project Restart earlier this month has been received with great enthusiasm and is already having positive impact on community care providers across the country.
1 year ago

iRemedy Launches Project Restart to Provide Underfunded Community Health Centers and Clinics with Free Medical Supplies

Project Restart
STUART, FL – August 5, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, today announced the formation of Project Restart, an initiative to help address the severe shortage of medical supplies in demand by local, underfunded community health centers and clinics.
1 year ago

iRemedy and Verséa Holdings Team to Provide COVID-19 Rapid Test Serology Kits to U.S. Medical Providers

The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy ecommerce platform, and Verséa Holdings, a U.S.-based healthcare company focused on clinical research and novel scientific discoveries and products, today jointly announced the commercial availability of a COVID-19 Rapid Test Serology Kit that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for administration by U.S. healthcare providers in testing patients for coronavirus infection.
1 year ago

iRemedy to Lead Formation of The American Medical Manufacturing Coalition

Coalition’s Aim Will Be to Fully Align the Security, Economic, Social and Geopolitical Interests of Key Stakeholders in the U.S. Healthcare Supply Chain through the Manufacture and Distribution of Medical Devices/Equipment, Supplies and Drugs Made in America
1 year ago

iRemedy Provides Essential Protective Equipment to Arizona Healthcare Workers and First Responders at Peak Time

Innovative medical supply solution avoids supply chain shortfalls and begins delivery of millions of units of verified, critically-needed PPE as COVID-19 case count rises
1 year ago